Our Mission

TREAT TB, a multi-year project funded by USAID, seeks to contribute to new knowledge regarding shorter, more tolerable treatment regimens for multidrug-resistant tuberculosis (MDR-TB) through clinical trials of priority research questions, targeted operational research benefitting global, regional, and country TB control efforts, and field evaluations of diagnostic tools.

FIND OUT MORE

 

Clinical Trials

TREAT TB has been implementing the STREAM clinical trial since 2012.  STREAM is the world’s largest recruited, multi-country clinical trial to examine shortened regimens for MDR-TB. It is also the first phase III trial to test the efficacy and safety of bedaquiline, one of the newest TB drugs, within a shortened treatment regimen.

FIND OUT MORE

Operational Research

Operational research (OR) plays a key role in generating the evidence needed to guide policies and programs. TREAT TB has conducted in-person OR training courses for health professionals in high-TB burden countries, and produced several free online educational resources.

FIND OUT MORE

Capacity Building

TREAT TB strengthens the institutions required to ensure the impact of our research is sustainable by building local capacity to diagnose, treat, and conduct research on MDR-TB. TREAT TB supports specialized training for stakeholders, including STREAM study teams, regularly covering key aspects of clinical trial implementation.

FIND OUT MORE

Community Engagement

TREAT TB supports community engagement activities at all STREAM clinical trial sites to ensure that community stakeholders are equipped to collaborate on the trial and future research, and are consulted throughout the research cycle. STREAM community advisory boards provide a crucial link between the community and the research team.

FIND OUT MORE

Technical Assistance

TREAT TB provides technical assistance to national TB programs to improve TB control in high-burden settings. In the Philippines, TREAT TB has provided a comprehensive package of technical assistance to support national scale-up of the standard short treatment regimen for MDR-TB and strengthen capacity to conduct operational research.

FIND OUT MORE

Latest News

The Importance of Supply Chain Management in Clinical Trials

Read more

7th All-CAB Webinar discusses influencing policy through CAB advocacy

In late July, more than 45 STREAM community engagement (CE) participants attended the 7th STREAM All-CAB webinar to explore how they can improve TB pr... Read more
MORE NEWS